The discussion was moderated by Sergey Tolstobrov, Head of the Department for the Development of Economic Territories at NANOLEK, Executive Director of the biopharmaceutical cluster “Vyatka-Biopolis”.
The following experts delivered their speeches at the event: Mikhail Nekrasov, CEO of NANOLEK, Raif Vasilov, President of Russian Society of Biotechnologists, Sergey Litvinets, Vice-Rector of Vyatka State University. Experts fr om the Ministry of economic development and business support of the Kirov region, representatives of small businesses, leaders of biopharmaceutical and biotechnological clusters delivered their reports as well.
The participants shared the opinion that the authorities, educational and research centers, industrial and business experts should join forces to build a common platform wh ere everyone could exchange their experience and to work out a unified development strategy. For example, the Ministry of economic development and business support of the Kirov region shared the details about efforts to set up the Biopolis special economic zone.
Sergey Litvinets demonstrated the capabilities of Vyatka State University in the field of research that help implement projects of innovative biotechnological companies and achieve better efficiency of project implementation with the assistance of clusters.
At the tail end of the meeting the participants discussed decisions on interaction between the members to be taken to improve the efficiency of companies, talked about the necessary measures of governmental support for participants, the creation of a “one-stop shop” to address issues covering product certification and promotion of biotechnological products.
Mikhail Nekrasov: “Historically, the Kirov region is the cradle of biotechnology. As usual, the region performs well in the level of industrial development and excellently trained young professionals. The Biopolis research and education center was established at the premises of our biopharmaceutical complex NANOLEK on the initiative of the Governor of the Kirov region Igor Vasiliev and is about to become a large-scale project both in the region and on a global scale. This will enable us to strengthen and scale up the biotechnological capacities for the production of the latest, state-of-the-art innovative and much-in-demand immunological drugs. We have done a lot together, and there is still a lot of work ahead.”